Evidence map›Paper›PMID 25480889›Full record

ArticleHuman molecular genetics2015

Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains.

Guang Bai, Iris Cheung, Hennady P Shulha, Joana E Coelho, Ping Li, Xianjun Dong, Mira Jakovcevski, Yumei Wang, Anastasia Grigorenko, Yan Jiang and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Epigenetic regulation in Huntington's disease.Neurochemistry international · 2021
    Review
  19. Histone Methylation Regulation in Neurodegenerative Disorders.International journal of molecular sciences · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Guang BaiDepartment of Neural and Pain Sciences, University of Maryland Dental School, Baltimore, MD 21201, USA.
Iris CheungBrudnick Neuropsychiatric Research Institute.
Hennady P ShulhaProgram in Bioinformatics and Integrative Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01604, USA.
Joana E CoelhoDepartment of Neurology, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA.
Ping LiDepartment of Neurology, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA.
Xianjun DongProgram in Bioinformatics and Integrative Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01604, USA.
Mira JakovcevskiBrudnick Neuropsychiatric Research Institute.
Yumei WangDepartment of Neurology, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA.
Anastasia GrigorenkoBrudnick Neuropsychiatric Research Institute.
Yan JiangFriedman Brain Institute, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA.
Andrew HossDepartment of Neurology, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA.
Krupal PatelDepartment of Neural and Pain Sciences, University of Maryland Dental School, Baltimore, MD 21201, USA.
Ming ZhengDepartment of Neural and Pain Sciences, University of Maryland Dental School, Baltimore, MD 21201, USA.
Evgeny RogaevBrudnick Neuropsychiatric Research Institute.
Richard H MyersDepartment of Neurology, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA, Genome Science Institute, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA.
Zhiping WengProgram in Bioinformatics and Integrative Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01604, USA.
Schahram AkbarianBrudnick Neuropsychiatric Research Institute, Friedman Brain Institute, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA.
Jiang-Fan ChenDepartment of Neurology, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA, chenjf@bu.edu.
Boston University · USUniversity of Maryland, Baltimore · USIcahn School of Medicine at Mount Sinai · US

Funding

Epigenetic Markers in Huntington's disease BrainR01NS073947 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MYERS, RICHARD H · 2011 to 2015
$3.1M
NOVEL BENEFIT OF A2A RECEPTOR INACTIVATION IN PD MODELSR01NS041083 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI CHEN, JIANG-FAN · 2001 to 2013
$3.1M
Dopaminergic Epigenomes from Human BrainR21NS076958 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AKBARIAN, SCHAHRAM, BANNON, MICHAEL J · 2012 to 2013
$460k
NINDS NIH HHS 1R01NS073947NINDS NIH HHS NS041083-07NINDS NIH HHS R01 NS073947NINDS NIH HHS R21NS076958
6 · The paper itself

Abstract

To investigate epigenetic contributions to Huntington's disease (HD) pathogenesis, we carried out genome-wide mapping of the transcriptional mark, trimethyl-histone H3-lysine 4 (H3K4me3) in neuronal nuclei extracted from prefrontal cortex of HD cases and controls using chromatin immunoprecipitation followed by deep-sequencing. Neuron-specific mapping of the genome-wide distribution of H3K4me3 revealed 136 differentially enriched loci associated with genes implicated in neuronal development and neurodegeneration, including GPR3, TMEM106B, PDIA6 and the Notch signaling genes hairy and enhancer of split 4 (HES4) and JAGGED2, supporting the view that the neuronal epigenome is affected in HD. Importantly, loss of H3K4me3 at CpG-rich sequences on the HES4 promoter was associated with excessive DNA methylation, reduced binding of nuclear proteins to the methylated region and altered expression of HES4 and HES4 targeted genes MASH1 and P21 involved in striatal development. Moreover, hypermethylation of HES4 promoter sequences was strikingly correlated with measures of striatal degeneration and age-of-onset in a cohort of 25 HD brains (r = 0.56, P = 0.006). Lastly, shRNA knockdown of HES4 in human neuroblastoma cells altered MASH1 and P21 mRNA expression and markedly increased mutated HTT-induced aggregates and cell death. These findings, taken together, suggest that epigenetic dysregulation of HES4 could play a critical role in modifying HD disease pathogenesis and severity.

Indexed as

Epigenesis, GeneticAdultAutopsyBasic Helix-Loop-Helix ProteinsCase-Control StudiesCell Line, TumorChromatin ImmunoprecipitationDNA MethylationFemaleGenetic LociGenetic MarkersGenome-Wide Association StudyHigh-Throughput Nucleotide SequencingHomeodomain ProteinsHumansHuntington DiseaseASCL1 protein, humanBasic Helix-Loop-Helix ProteinsGenetic MarkersHES1 protein, humanHomeodomain ProteinsRNA, MessengerRNA, Small InterferingTranscription Factor HES-1

Identifiers

PMID25480889
PMCPMC4321450
OpenAlexW2135397980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.